Wanbury Limited has informed the Exchange regarding a press release dated October 08, 2026, titled "Press Release regarding filing new Drug Master File (DMF) in South Africa for Tramadol HC1 API".
Filed with NSE · ISIN INE107F01022 · · 1 page · English
Earlier from Wanbury
- Wanbury Limited Press Release Aug 13 2026
- Wanbury Limited Press Release Aug 11 2026
- Wanbury Limited Press Release Jul 30 2026
- Wanbury Limited Press Release Jun 25 2026
- Wanbury Limited Press Release Jun 10 2026
Later from Wanbury
- Wanbury Limited has informed the Exchange regarding a press release dated October 12, 2026, titled "Press Release - Wanbury Skin Health Limited (Subsidiary of Wanbury Limited) Launches its berrysoft baby Product Range Across Multiple States in India, Marks Strategic Entry in The Paediatric Dermatology Segment.".
- Wanbury Limited has informed the Exchange regarding a press release dated October 16, 2026, titled "Wanbury Limited Regulatory Progress in API Business, New Business Opportunities and Operational Achievements".
- Wanbury Limited has informed the Exchange regarding a press release dated October 19, 2026, titled "Wanbury Limited Awards for Tanuku and Patalganga Facilities".
Follow Wanbury into a list and get an email when it puts out news.
Follow Wanbury